Literature DB >> 19222999

Reassessment of the role of FKBP38 in the Rheb/mTORC1 pathway.

Katharina Uhlenbrock1, Matthias Weiwad, Reinhard Wetzker, Gunter Fischer, Alfred Wittinghofer, Ignacio Rubio.   

Abstract

The small G-protein Rheb regulates cell growth via the mTORC1 complex by incompletely understood mechanisms. Recent studies document that Rheb activates mTORC1 via direct, GTP-dependent interaction with the peptidyl-prolyl-cis/trans-isomerase FKBP38, which is proposed to act as an inhibitor of mTORC1. We have conducted a comprehensive biochemical characterization of the Rheb/FKBP38 interaction. Using three different in vitro assays we did not detect an interaction between Rheb and FKBP38. Cell biological experiments illustrate that FKBP38 plays only a very minor, if any, role in mTORC1 activation. Our data document that FKBP38 is not the long-sought Rheb effector linking Rheb to mTORC1 activation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19222999     DOI: 10.1016/j.febslet.2009.02.015

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  24 in total

1.  The abundance and activation of mTORC1 regulators in skeletal muscle of neonatal pigs are modulated by insulin, amino acids, and age.

Authors:  Agus Suryawan; Teresa A Davis
Journal:  J Appl Physiol (1985)       Date:  2010-08-19

Review 2.  The role of mammalian target of rapamycin (mTOR) in the regulation of pancreatic β-cell mass: implications in the development of type-2 diabetes.

Authors:  Jianling Xie; Terence P Herbert
Journal:  Cell Mol Life Sci       Date:  2011-11-09       Impact factor: 9.261

3.  FKBPs and the Akt/mTOR pathway.

Authors:  Felix Hausch; Christian Kozany; Marily Theodoropoulou; Anne-Katrin Fabian
Journal:  Cell Cycle       Date:  2013-07-01       Impact factor: 4.534

Review 4.  Regulation of mTORC1 by PI3K signaling.

Authors:  Christian C Dibble; Lewis C Cantley
Journal:  Trends Cell Biol       Date:  2015-07-06       Impact factor: 20.808

5.  Direct control of mitochondrial function by mTOR.

Authors:  Arvind Ramanathan; Stuart L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

6.  Phosphatidic acid activates mammalian target of rapamycin complex 1 (mTORC1) kinase by displacing FK506 binding protein 38 (FKBP38) and exerting an allosteric effect.

Authors:  Mee-Sup Yoon; Yuting Sun; Edwin Arauz; Yu Jiang; Jie Chen
Journal:  J Biol Chem       Date:  2011-07-07       Impact factor: 5.157

7.  Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin.

Authors:  Jianing Xu; Can G Pham; Steven K Albanese; Yiyu Dong; Toshinao Oyama; Chung-Han Lee; Vanessa Rodrik-Outmezguine; Zhan Yao; Song Han; David Chen; Daniel L Parton; John D Chodera; Neal Rosen; Emily H Cheng; James J Hsieh
Journal:  J Clin Invest       Date:  2016-08-02       Impact factor: 14.808

8.  FKBP38 peptidylprolyl isomerase promotes the folding of cystic fibrosis transmembrane conductance regulator in the endoplasmic reticulum.

Authors:  Yeshavanth K Banasavadi-Siddegowda; Junbo Mai; Yifei Fan; Sumit Bhattacharya; David R Giovannucci; Edwin R Sanchez; Gunter Fischer; Xiaodong Wang
Journal:  J Biol Chem       Date:  2011-10-26       Impact factor: 5.157

9.  Large FK506-binding proteins shape the pharmacology of rapamycin.

Authors:  Andreas M März; Anne-Katrin Fabian; Christian Kozany; Andreas Bracher; Felix Hausch
Journal:  Mol Cell Biol       Date:  2013-01-28       Impact factor: 4.272

10.  Glycolytic flux signals to mTOR through glyceraldehyde-3-phosphate dehydrogenase-mediated regulation of Rheb.

Authors:  Mi Nam Lee; Sang Hoon Ha; Jaeyoon Kim; Ara Koh; Chang Sup Lee; Jung Hwan Kim; Hyeona Jeon; Do-Hyung Kim; Pann-Ghill Suh; Sung Ho Ryu
Journal:  Mol Cell Biol       Date:  2009-05-18       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.